AU2018904117A0 - Polypeptides and uses thereof - Google Patents

Polypeptides and uses thereof

Info

Publication number
AU2018904117A0
AU2018904117A0 AU2018904117A AU2018904117A AU2018904117A0 AU 2018904117 A0 AU2018904117 A0 AU 2018904117A0 AU 2018904117 A AU2018904117 A AU 2018904117A AU 2018904117 A AU2018904117 A AU 2018904117A AU 2018904117 A0 AU2018904117 A0 AU 2018904117A0
Authority
AU
Australia
Prior art keywords
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2018904117A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Peter MacCallum Cancer Institute
Original Assignee
Peter MacCallum Cancer Institute
Filing date
Publication date
Application filed by Peter MacCallum Cancer Institute filed Critical Peter MacCallum Cancer Institute
Publication of AU2018904117A0 publication Critical patent/AU2018904117A0/en
Priority to PCT/AU2019/051189 priority Critical patent/WO2020087116A1/en
Priority to EP19879319.2A priority patent/EP3877417A4/en
Priority to US17/289,997 priority patent/US11866504B2/en
Priority to CA3117079A priority patent/CA3117079A1/en
Priority to CN201980075175.XA priority patent/CN113195535A/en
Priority to KR1020217016400A priority patent/KR20210108361A/en
Priority to AU2019370618A priority patent/AU2019370618C1/en
Priority to SG11202104180WA priority patent/SG11202104180WA/en
Priority to JP2021525181A priority patent/JP2022528024A/en
Priority to AU2022263573A priority patent/AU2022263573A1/en
Priority to US18/507,157 priority patent/US20240150482A1/en
Abandoned legal-status Critical Current

Links

AU2018904117A 2018-10-30 2018-10-30 Polypeptides and uses thereof Abandoned AU2018904117A0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
JP2021525181A JP2022528024A (en) 2018-10-30 2019-10-29 Bispecific polypeptides and their use to engage antigen-presenting cells with immune cells expressing CAR
CN201980075175.XA CN113195535A (en) 2018-10-30 2019-10-29 Bispecific polypeptides for linking CAR-expressing immune cells to antigen presenting cells and uses thereof
EP19879319.2A EP3877417A4 (en) 2018-10-30 2019-10-29 Bispecific polypeptides for engagement of car expressing immune cells with antigen presenting cells and uses thereof
US17/289,997 US11866504B2 (en) 2018-10-30 2019-10-29 Bispecific polypeptides for engagement of CAR expressing immune cells with antigen presenting cells and uses thereof
CA3117079A CA3117079A1 (en) 2018-10-30 2019-10-29 Bispecific polypeptides for engagement of car expressing immune cells with antigen presenting cells and uses thereof
PCT/AU2019/051189 WO2020087116A1 (en) 2018-10-30 2019-10-29 Bispecific polypeptides for engagement of car expressing immune cells with antigen presenting cells and uses thereof
KR1020217016400A KR20210108361A (en) 2018-10-30 2019-10-29 Allogeneic polypeptide that binds CAR-expressing immune cells to antigen-presenting cells and uses thereof
AU2019370618A AU2019370618C1 (en) 2018-10-30 2019-10-29 Bispecific polypeptides for engagement of CAR expressing immune cells with antigen presenting cells and uses thereof
SG11202104180WA SG11202104180WA (en) 2018-10-30 2019-10-29 Bispecific polypeptides for engagement of car expressing immune cells with antigen presenting cells and uses thereof
AU2022263573A AU2022263573A1 (en) 2018-10-30 2022-11-04 Bispecific polypeptides for engagement of CAR expressing immune cells with antigen presenting cells and uses thereof
US18/507,157 US20240150482A1 (en) 2018-10-30 2023-11-13 Bispecific polypeptides for engagement of car expressing immune cells with antigen presenting cells and uses thereof

Publications (1)

Publication Number Publication Date
AU2018904117A0 true AU2018904117A0 (en) 2018-11-15

Family

ID=

Similar Documents

Publication Publication Date Title
EP3810182A4 (en) Neoantigens and uses thereof
EP3810180A4 (en) Neoantigens and uses thereof
EP3710067A4 (en) D-domain containing polypeptides and uses thereof
EP3841096A4 (en) Pyridinylmethylenepiperidine derivatives and uses thereof
EP3810172A4 (en) Heterodimeric proteins and uses thereof
EP3764988A4 (en) Gel-forming polypeptides
IL287781A (en) Clec12a-binding polypeptides and uses thereof
EP3813861A4 (en) Heparin-associated polypeptides and uses thereof
IL280808A (en) Ox40-binding polypeptides and uses thereof
IL287782A (en) Cd33-binding polypeptides and uses thereof
EP3728294A4 (en) Insecticidal polypeptides and uses thereof
EP3740228A4 (en) Peptides and uses thereof
EP3762364A4 (en) Pyrrolidineamide derivatives and uses thereof
GB201819200D0 (en) Polypeptide and uses thereof
EP3808357A4 (en) Composition and uses thereof
EP3882263A4 (en) Glucagon-derived peptide and use thereof
EP3816186A4 (en) Pd-l1-binding polypeptide and use thereof
EP3856755A4 (en) Terpinoid derivatives and uses thereof
EP3802565A4 (en) Polypeptides
EP3630795A4 (en) Engineered aldolase polypeptides and uses thereof
GB2603645B (en) Polypeptides having anti-senescent effects and uses thereof
AU2019350356A1 (en) Arginase1 polypeptides
EP3684796A4 (en) Succinate-regulating polypeptides and use thereof
EP3611181A4 (en) Atp1a1-targeting polypeptide and use
EP4023663A4 (en) Polypeptide and application thereof